China's National Medical Products Administration (NMPA) approved AGAMREE® for the treatment of Duchenne muscular dystrophy in patients aged 4 years and older; This approval makes ...
The global blood and bone marrow cancer drug market size was US$ 39.1 billion in 2021. The global blood and bone marrow cancer drug market is forecast to grow to US$ 79.8 billion by 2030 by ...
The human fossils, along with a large number of fossilized animal bones and stone tools, have been unearthed at the Hualongdong site in Dongzhi County, east China's Anhui Province ...
The China Marrow Donor Program (CMDP) announced on Friday that, to date, it has facilitated 19,000 hematopoietic stem cell donations from unrelated donors since its launch in 2001. The CMDP, the world ...
Researchers have developed a revolutionary bone graft substitute inspired by coral which not only promotes faster healing but dissolves naturally in the body after the repair is complete.